Related references
Note: Only part of the references are listed.SARS-CoV-2 Infectivity and Neurological Targets in the Brain
Walter J. Lukiw et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2
Shaopeng Yu et al.
PHYTOMEDICINE (2021)
Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2
Shuai Ge et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Blocking Effect of Demethylzeylasteral on the Interaction between Human ACE2 Protein and SARS-CoV-2 RBD Protein Discovered Using SPR Technology
Zhi-Ling Zhu et al.
MOLECULES (2021)
Inhibitory Effects and Surface Plasmon Resonance-Based Binding Affinities of Dietary Hydrolyzable Tannins and Their Gut Microbial Metabolites on SARS-CoV-2 Main Protease
Huifang Li et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
Jie Mei et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
A comprehensive review on plasmonic-based biosensors used in viral diagnostics
Anand M. Shrivastav et al.
COMMUNICATIONS BIOLOGY (2021)
Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands
Yuhong Cao et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
Jiayu Lu et al.
LIFE SCIENCES (2021)
Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography
Jiapan Gao et al.
PHYTOTHERAPY RESEARCH (2021)
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
Santosh Kumar Singh et al.
JOURNAL OF OVARIAN RESEARCH (2021)
Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells
Huan Xu et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
Yajing Hou et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Ashuai Du et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Synthesis and Antiviral Activity of Camphene Derivatives against Different Types of Viruses
Anastasiya S. Sokolova et al.
MOLECULES (2021)
The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro
Raphael J. Eberle et al.
VIRUSES-BASEL (2021)
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Interactions
Christopher J. Day et al.
MBIO (2021)
Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
Jingyi Yang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System
Takeru Ebihara et al.
MOLECULAR BIOTECHNOLOGY (2021)
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
Shuai Ge et al.
VIROLOGY (2021)
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
Gang Ye et al.
ELIFE (2021)
Corilagin and 1,3,6-Tri-O-galloy-β-d-glucose: potential inhibitors of SARS-CoV-2 variants
Vincent Binette et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
Critical assessment of relevant methods in the field of biosensors with direct optical detection based on fibers and waveguides using plasmonic, resonance, and interference effects
Guenter Gauglitz
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro et al.
JAMA CARDIOLOGY (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
The protein expression profile of ACE2 in human tissues
Feria Hikmet et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Supriya Ravichandran et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients
Susanne N. Walker et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Entry Inhibitors: Efficient Means to Block Viral Infection
Gourab Prasad Pattnaik et al.
JOURNAL OF MEMBRANE BIOLOGY (2020)
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
Praveen Kumar Tripathi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
Nan Wang et al.
PHYTOMEDICINE (2020)
Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease
Akshita Gupta et al.
ACS OMEGA (2020)
The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses
Wei Xu et al.
FRONTIERS IN MICROBIOLOGY (2018)
Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
Tim Kaminski et al.
ACS SENSORS (2017)
Systematic screening of viral entry inhibitors using surface plasmon resonance
Penmetcha K. R. Kumar
REVIEWS IN MEDICAL VIROLOGY (2017)
Surface Plasmon Resonance Clinical Biosensors for Medical Diagnostics
Jean-Francois Masson
ACS SENSORS (2017)
Developments in SPR Fragment Screening
Alain Chavanieu et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Surface Plasmon Resonance (SPR) Biosensors in Pharmaceutical Analysis
Andreea Olaru et al.
CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY (2015)
Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists
Han Cheng et al.
JOURNAL OF VIROLOGY (2015)
Broad-spectrum antivirals against viral fusion
Frederic Vigant et al.
NATURE REVIEWS MICROBIOLOGY (2015)
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Rolf Hilgenfeld
FEBS JOURNAL (2014)
Fragment screening by SPR and advanced application to GPCRs
Claire A. Shepherd et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2014)
Fragment-Based Identification of a Locus in the Sec7 Domain of Arno for the Design of Protein-Protein Interaction Inhibitors
Jad Rouhana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
High-Throughput Fragment Screening by Affinity LC-MS
Minh-Dao Duong-Thi et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Weak affinity chromatography as a new approach for fragment screening in drug discovery
Minh-Dao Duong-Thi et al.
ANALYTICAL BIOCHEMISTRY (2011)
A comparative study of fragment screening methods on the p38α kinase: new methods, new insights
Scott J. Pollack et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Adding calorimetric data to decision making in lead discovery: a hot tip
John E. Ladbury et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12
Andreas Boettcher et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Surface plasmon resonance sensors for detection of chemical and biological species
Jiri Homola
CHEMICAL REVIEWS (2008)
A decade of fragment-based drug design: strategic advances and lessons learned
Philip J. Hajduk et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
TINS, target immobilized NMR screening: An efficient and sensitive method for ligand discovery
S Vanwetswinkel et al.
CHEMISTRY & BIOLOGY (2005)
Affinity capillary electrophoresis for the screening of novel antimicrobial targets
LM Lewis et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
High-throughput crystallography for lead discovery in drug design
TL Blundell et al.
NATURE REVIEWS DRUG DISCOVERY (2002)